Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phillip M. Devlin, M.D.

Co-Author

This page shows the publications co-authored by Phillip Devlin and Ivan Buzurovic.
Connection Strength

4.453
  1. Selection criteria for high-dose-rate surface brachytherapy and electron beam therapy in cutaneous oncology. J Contemp Brachytherapy. 2021 Apr; 13(2):195-204.
    View in: PubMed
    Score: 0.931
  2. Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis. J Contemp Brachytherapy. 2017 Jun; 9(3):263-269.
    View in: PubMed
    Score: 0.714
  3. Clinical implementation of a novel applicator in high-dose-rate brachytherapy treatment of esophageal cancer. J Contemp Brachytherapy. 2016 Aug; 8(4):319-25.
    View in: PubMed
    Score: 0.675
  4. Feasibility of magnetic resonance-only high-dose-rate surface brachytherapy for clinical application. Med Phys. 2021 Nov; 48(11):7313-7322.
    View in: PubMed
    Score: 0.240
  5. Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand. J Contemp Brachytherapy. 2020 Feb; 12(1):48-52.
    View in: PubMed
    Score: 0.215
  6. Development and clinical implementation of semi-automated treatment planning including 3D printable applicator holders in complex skin brachytherapy. Med Phys. 2020 Mar; 47(3):869-879.
    View in: PubMed
    Score: 0.213
  7. Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol. 2020 Jan - Feb; 10(1):8-20.
    View in: PubMed
    Score: 0.212
  8. American College of Radiology-American Brachytherapy Society practice parameter for electronically generated low-energy radiation sources. Brachytherapy. 2017 Nov - Dec; 16(6):1083-1090.
    View in: PubMed
    Score: 0.182
  9. SU-G-201-04: Can the Dynamic Library of Flap Applicators Replace Treatment Planning in Surface Brachytherapy? Med Phys. 2016 Jun; 43(6):3623.
    View in: PubMed
    Score: 0.166
  10. SU-E-T-165: Characterization of Dose Distributions in High-Dose-Rate Surface Brachytherapy. Med Phys. 2015 Jun; 42(6):3369.
    View in: PubMed
    Score: 0.155
  11. SU-E-T-362: Automatic Catheter Reconstruction of Flap Applicators in HDR Surface Brachytherapy. Med Phys. 2014 Jun; 41(6):308.
    View in: PubMed
    Score: 0.145
  12. Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face. J Contemp Brachytherapy. 2021 Apr; 13(2):172-178.
    View in: PubMed
    Score: 0.058
  13. Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT. Sarcoma. 2020; 2020:7615248.
    View in: PubMed
    Score: 0.056
  14. Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer. Urol Oncol. 2018 04; 36(4):157.e15-157.e20.
    View in: PubMed
    Score: 0.046
  15. Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):904-911.
    View in: PubMed
    Score: 0.045
  16. Dose comparison between TG-43-based calculations and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions. Brachytherapy. 2017 Sep - Oct; 16(5):1065-1072.
    View in: PubMed
    Score: 0.045
  17. The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy. Brachytherapy. 2017 May - Jun; 16(3):579-585.
    View in: PubMed
    Score: 0.044
  18. Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience. Gynecol Oncol. 2016 Dec; 143(3):545-551.
    View in: PubMed
    Score: 0.043
  19. WE-DE-201-11: Sensitivity and Specificity of Verification Methods Based On Total Reference Air Kerma (TRAK) Or On User Provided Dose Points for Graphically Planned Skin HDR Brachytherapy. Med Phys. 2016 Jun; 43(6):3810-3811.
    View in: PubMed
    Score: 0.042
  20. SU-E-T-301: Dosimetric Comparison Between Adaptive and Rectilinear Template-Based Prostate Seed Implants. Med Phys. 2015 Jun; 42(6):3402.
    View in: PubMed
    Score: 0.039
  21. SU-E-T-413: Examining Acquisition Rate for Using MatriXX Ion Chamber Array to Measure HDR Brachytherapy Treatments. Med Phys. 2015 Jun; 42(6):3429.
    View in: PubMed
    Score: 0.039
  22. SU-E-T-783: Using Matrixx to Determine Transit Dose Contribution Over Clinically Useful Limits of HDR Source Activity. Med Phys. 2015 Jun; 42(6):3517.
    View in: PubMed
    Score: 0.039
  23. Independent brachytherapy plan verification software: improving efficacy and efficiency. Radiother Oncol. 2014 Dec; 113(3):420-4.
    View in: PubMed
    Score: 0.037
  24. Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series. Radiat Oncol. 2014 Sep 09; 9:200.
    View in: PubMed
    Score: 0.037
  25. WE-A-17A-03: Catheter Digitization in High-Dose-Rate Brachytherapy with the Assistance of An Electromagnetic (EM) Tracking System. Med Phys. 2014 Jun; 41(6):487-488.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.